211 related articles for article (PubMed ID: 35563446)
1. Sulfated Hyaluronan Binds to Heparanase and Blocks Its Enzymatic and Cellular Actions in Carcinoma Cells.
Shi J; Kanoya R; Tani Y; Ishikawa S; Maeda R; Suzuki S; Kawanami F; Miyagawa N; Takahashi K; Oku T; Yamamoto A; Fukuzawa K; Nakajima M; Irimura T; Higashi N
Int J Mol Sci; 2022 May; 23(9):. PubMed ID: 35563446
[TBL] [Abstract][Full Text] [Related]
2. Chondroitin sulfate E blocks enzymatic action of heparanase and heparanase-induced cellular responses.
Higashi N; Maeda R; Sesoko N; Isono M; Ishikawa S; Tani Y; Takahashi K; Oku T; Higashi K; Onishi S; Nakajima M; Irimura T
Biochem Biophys Res Commun; 2019 Nov; 520(1):152-158. PubMed ID: 31582210
[TBL] [Abstract][Full Text] [Related]
3. Identification and characterization of heparin/heparan sulfate binding domains of the endoglycosidase heparanase.
Levy-Adam F; Abboud-Jarrous G; Guerrini M; Beccati D; Vlodavsky I; Ilan N
J Biol Chem; 2005 May; 280(21):20457-66. PubMed ID: 15760902
[TBL] [Abstract][Full Text] [Related]
4. Structural requirements for inhibition of melanoma lung colonization by heparanase inhibiting species of heparin.
Bitan M; Mohsen M; Levi E; Wygoda MR; Miao HQ; Lider O; Svahn CM; Ekre HP; Ishai-Michaeli R; Bar-Shavit R
Isr J Med Sci; 1995; 31(2-3):106-18. PubMed ID: 7744578
[TBL] [Abstract][Full Text] [Related]
5. Modulation of the heparanase-inhibiting activity of heparin through selective desulfation, graded N-acetylation, and glycol splitting.
Naggi A; Casu B; Perez M; Torri G; Cassinelli G; Penco S; Pisano C; Giannini G; Ishai-Michaeli R; Vlodavsky I
J Biol Chem; 2005 Apr; 280(13):12103-13. PubMed ID: 15647251
[TBL] [Abstract][Full Text] [Related]
6. Chemically modified heparins as inhibitors of heparan sulfate specific endo-beta-glucuronidase (heparanase) of metastatic melanoma cells.
Irimura T; Nakajima M; Nicolson GL
Biochemistry; 1986 Sep; 25(18):5322-8. PubMed ID: 3768351
[TBL] [Abstract][Full Text] [Related]
7. Computational analyses of the catalytic and heparin-binding sites and their interactions with glycosaminoglycans in glycoside hydrolase family 79 endo-β-D-glucuronidase (heparanase).
Gandhi NS; Freeman C; Parish CR; Mancera RL
Glycobiology; 2012 Jan; 22(1):35-55. PubMed ID: 21746763
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of heparanase-mediated degradation of extracellular matrix heparan sulfate by non-anticoagulant heparin species.
Bar-Ner M; Eldor A; Wasserman L; Matzner Y; Cohen IR; Fuks Z; Vlodavsky I
Blood; 1987 Aug; 70(2):551-7. PubMed ID: 2955820
[TBL] [Abstract][Full Text] [Related]
9. Characterization of heparanase from a rat parathyroid cell line.
Podyma-Inoue KA; Yokote H; Sakaguchi K; Ikuta M; Yanagishita M
J Biol Chem; 2002 Sep; 277(36):32459-65. PubMed ID: 12077130
[TBL] [Abstract][Full Text] [Related]
10. Murine macrophage heparanase: inhibition and comparison with metastatic tumor cells.
Savion N; Disatnik MH; Nevo Z
J Cell Physiol; 1987 Jan; 130(1):77-84. PubMed ID: 3805131
[TBL] [Abstract][Full Text] [Related]
11. Hyaluronan/collagen hydrogels containing sulfated hyaluronan improve wound healing by sustained release of heparin-binding EGF-like growth factor.
Thönes S; Rother S; Wippold T; Blaszkiewicz J; Balamurugan K; Moeller S; Ruiz-Gómez G; Schnabelrauch M; Scharnweber D; Saalbach A; Rademann J; Pisabarro MT; Hintze V; Anderegg U
Acta Biomater; 2019 Mar; 86():135-147. PubMed ID: 30660005
[TBL] [Abstract][Full Text] [Related]
12. Heparanase - Discovery and Targets.
Lindahl U; Li JP
Adv Exp Med Biol; 2020; 1221():61-69. PubMed ID: 32274706
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of tumor metastasis by heparanase inhibiting species of heparin.
Vlodavsky I; Mohsen M; Lider O; Svahn CM; Ekre HP; Vigoda M; Ishai-Michaeli R; Peretz T
Invasion Metastasis; 1994-1995; 14(1-6):290-302. PubMed ID: 7657522
[TBL] [Abstract][Full Text] [Related]
14. Design of an Ultralow Molecular Weight Heparin That Resists Heparanase Biodegradation.
Ham H; Xu Y; Haller CA; Dai E; Stancanelli E; Liu J; Chaikof EL
J Med Chem; 2023 Feb; 66(3):2194-2203. PubMed ID: 36706244
[TBL] [Abstract][Full Text] [Related]
15. Multi-faceted substrate specificity of heparanase.
Peterson SB; Liu J
Matrix Biol; 2013 Jun; 32(5):223-7. PubMed ID: 23499529
[TBL] [Abstract][Full Text] [Related]
16. Heparin interaction with a receptor on hyperglycemic dividing cells prevents intracellular hyaluronan synthesis and autophagy responses in models of type 1 diabetes.
Wang A; Sankaranarayanan NV; Yanagishita M; Templeton DM; Desai UR; Sugahara K; Wang CP; Hascall VC
Matrix Biol; 2015 Oct; 48():36-41. PubMed ID: 25892563
[TBL] [Abstract][Full Text] [Related]
17. Modulations of glypican-1 heparan sulfate structure by inhibition of endogenous polyamine synthesis. Mapping of spermine-binding sites and heparanase, heparin lyase, and nitric oxide/nitrite cleavage sites.
Ding K; Sandgren S; Mani K; Belting M; Fransson LA
J Biol Chem; 2001 Dec; 276(50):46779-91. PubMed ID: 11577085
[TBL] [Abstract][Full Text] [Related]
18. Structural recognition by recombinant human heparanase that plays critical roles in tumor metastasis. Hierarchical sulfate groups with different effects and the essential target disulfated trisaccharide sequence.
Okada Y; Yamada S; Toyoshima M; Dong J; Nakajima M; Sugahara K
J Biol Chem; 2002 Nov; 277(45):42488-95. PubMed ID: 12213822
[TBL] [Abstract][Full Text] [Related]
19. Inhibition of heparanase activity and tumor metastasis by laminarin sulfate and synthetic phosphorothioate oligodeoxynucleotides.
Miao HQ; Elkin M; Aingorn E; Ishai-Michaeli R; Stein CA; Vlodavsky I
Int J Cancer; 1999 Oct; 83(3):424-31. PubMed ID: 10495437
[TBL] [Abstract][Full Text] [Related]
20. Cell surface localization of heparanase on macrophages regulates degradation of extracellular matrix heparan sulfate.
Sasaki N; Higashi N; Taka T; Nakajima M; Irimura T
J Immunol; 2004 Mar; 172(6):3830-5. PubMed ID: 15004189
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
